2022
Interplay of Lymphocytes with the Intestinal Microbiota in Children with Nonalcoholic Fatty Liver Disease
Liang T, Li D, Zunong J, Li M, Amaerjiang N, Xiao H, Khattab N, Vermund S, Hu Y. Interplay of Lymphocytes with the Intestinal Microbiota in Children with Nonalcoholic Fatty Liver Disease. Nutrients 2022, 14: 4641. PMID: 36364902, PMCID: PMC9657134, DOI: 10.3390/nu14214641.Peer-Reviewed Original ResearchConceptsNonalcoholic fatty liver diseaseFatty liver diseaseHigher lymphocyte countsLymphocyte countGut microbiotaLiver diseaseHealthy childrenGut microbiota dysbiosisEffect of lymphocytesProinflammatory bacteriaMicrobiota dysbiosisRisk factorsIntestinal microbiotaAbundance of BacteroidetesLymphocytesMicrobiotaChildrenOpportunistic pathogenDiseaseCountMetagenomic sequencingLow numberHigher numberDysbiosisGroup
2021
Predictors of non-alcoholic fatty liver disease in children
Li M, Shu W, Zunong J, Amaerjiang N, Xiao H, Li D, Vermund SH, Hu Y. Predictors of non-alcoholic fatty liver disease in children. Pediatric Research 2021, 92: 322-330. PMID: 34580427, DOI: 10.1038/s41390-021-01754-6.Peer-Reviewed Original ResearchConceptsNon-alcoholic fatty liver diseasePediatric non-alcoholic fatty liver diseaseAbdominal obesity indicatorsFatty liver diseaseBody composition indicatorsLiver diseaseObesity indicatorsDiscriminative performancePopulation-based child cohortClinical Trials RegistryOptimal screening toolComposition indicatorsCurve valuesTrials RegistryLiver damageWeight managementChild CohortAnthropometric indicatorsEarly identificationLogistic regressionEndocrine indicatorsScreening toolDiseaseSpearman correlationCharacteristic curve